Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Dapoxetine

A rapid, short-acting selective serotonin reuptake inhibitor, first approved in 2009 in Finland and Sweden to treat premature ejaculation. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?It was created as an antidepressant, but results in that role were disappointing and it was shelved: years later it found a second life in a completely different indication.

DapoxetineGo to the active ingredient →
DapoxetineActive ingredientDapoxetineCat. No. P-D016-001CAS 119356-77-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.